PMGC (ELAB) vs Matinas Biopharma (MTNB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Matinas Biopharma is the larger company by market cap ($2.8 million vs $2.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELAB | MTNB |
|---|---|---|
| Share price | $3.13 | $2.83 |
| Market cap | $2.53M | $2.77M |
| 1-day change | -2.04% | +2.17% |
| EPS (TTM) | $-1,748.36 | $-17.55 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2,671.20 | $28.95 |
| 52-week low | $2.59 | $2.27 |
| Distance from 52-week high | -99.88% | -90.22% |
| Average volume | 140.44K | 405.99K |
| Shares outstanding | 809.58K | 979.52K |
| Employees | 32 | 2 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About PMGC
ELAB stock →PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.
Healthcare · Biotechnology · 32 employees
About Matinas Biopharma
MTNB stock →Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides.
Healthcare · Biotechnology · 2 employees
ELAB vs MTNB FAQ
Which is bigger, PMGC or Matinas Biopharma?
Matinas Biopharma (MTNB) is larger, with a market capitalization of $2.77M compared with $2.53M for PMGC (ELAB).
Are PMGC and Matinas Biopharma in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.